Your browser doesn't support javascript.
loading
Liver sinusoidal obstruction syndrome associated with trastuzumab emtansine treatment for breast cancer.
Duret-Aupy, Nina; Lagarce, Laurence; Blouet, Anaise; Kettani, Sami; Conte, Cécile; Bourneau-Martin, Delphine; Drablier, Guillaume; Umlil, Amine; Briet, Marie.
Afiliação
  • Duret-Aupy N; Service de pharmacologie-toxicologie et centre régional de pharmacovigilance, CHU Angers, 49100 Angers, France.
  • Lagarce L; Service de pharmacologie-toxicologie et centre régional de pharmacovigilance, CHU Angers, 49100 Angers, France. Electronic address: lalagarce@chu-angers.fr.
  • Blouet A; Département d'oncologie, centre hospitalier de Cholet, 49300 Cholet, France.
  • Kettani S; Centre de pathologie de l'Ouest, 49004 Angers, France.
  • Conte C; Laboratoire de pharmacologie médicale et clinique, service de pharmacologie médicale et clinique, faculté de médecine, université Paul-Sabatier, CHU de Toulouse, 31000 Toulouse, France.
  • Bourneau-Martin D; Service de pharmacologie-toxicologie et centre régional de pharmacovigilance, CHU Angers, 49100 Angers, France.
  • Drablier G; Service de pharmacologie-toxicologie et centre régional de pharmacovigilance, CHU Angers, 49100 Angers, France.
  • Umlil A; CTIAP, centre hospitalier de Cholet, 49300 Cholet, France.
  • Briet M; Service de pharmacologie-toxicologie et centre régional de pharmacovigilance, CHU Angers, 49100 Angers, France; Inserm 1083, MitoVasc laboratory, CNRS 6214, Angers university, 49100 Angers, France.
Therapie ; 74(6): 675-677, 2019 12.
Article em En | MEDLINE | ID: mdl-31023619

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hepatopatia Veno-Oclusiva / Neoplasias da Mama / Antineoplásicos Imunológicos / Ado-Trastuzumab Emtansina Tipo de estudo: Diagnostic_studies / Risk_factors_studies Limite: Aged80 / Female / Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hepatopatia Veno-Oclusiva / Neoplasias da Mama / Antineoplásicos Imunológicos / Ado-Trastuzumab Emtansina Tipo de estudo: Diagnostic_studies / Risk_factors_studies Limite: Aged80 / Female / Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article